Should we monitor troponin up to peak value when evaluating for acute coronary syndrome?

Cleve Clin J Med. 2020 Jul 31;87(8):480-482. doi: 10.3949/ccjm.87a.18125.

Nolan Anderson¹, Samuel T Ives^{2

3}, Michelle D Carlson^{4

5}, Fred Apple^{6

7

8}

¹ Pediatric Residency Program, University of Washington, Seattle.
² Division of General Internal Medicine, Hennepin Healthcare, Minneapolis, MN [email protected].
³ Assistant Professor of Medicine, Department of Medicine, University of Minnesota, Minneapolis [email protected].
⁴ Division of Cardiology, Hennepin Healthcare, Minneapolis, MN.
⁵ Assistant Professor of Medicine, Department of Medicine, University of Minnesota, Minneapolis.
⁶ Co-Medical Director, Clinical & Forensic Toxicology Laboratory, Hennepin Healthcare/Hennepin County Medical Center.
⁷ Principal Investigator, Cardiac Biomarkers Trials Laboratory, Hennepin Healthcare Research Institute.
⁸ Professor, Laboratory Medicine & Pathology, University of Minnesota.

No abstract available

MeSH terms